Table 2.
Demographic and clinical parameters based on 25(OH)D category among patients undergoing KT.
| 25(OH)D levels | Race | Gender | BMI | Type of donor* | Bone fracture after KT | Immunosuppressive therapy | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| White | Non-White | Female | Male | Non-obese | Obese | Living donor | Cadaveric donor | No | Yes | CNI use | CNI non-use | |
| Deficient | 35 (34.3) | 21 (44.7) | 30 (35.7) | 26 (40) | 29 (36.7) | 27 (38.6) | 28 (34.1) | 28 (41.8) | 52 (38.8) | 4 (26.6) | 44 (41.1) | 12 (28.6) |
| Insufficient | 43 (42.1) | 19 (40.4) | 35 (41.6) | 27 (41.5) | 34 (43) | 28 (40) | 31 (37.8) | 31 (46.3) | 53 (39.5) | 9 (60) | 43 (40.2) | 19 (45.2) |
| Normal | 24 (23.5) | 7 (14.8) | 19 (22.6) | 12 (18.5) | 16 (20.2) | 15 (21.4) | 23 (28) | 8 (12) | 29 (21.6) | 2 (13.3) | 20 (18.7) | 11 (26.2) |
| Total | 102 (100) | 47 (100) | 84 (100) | 65 (100) | 79 (100) | 70 (100) | 82 (100) | 67 (100) | 134 (100) | 15 (100) | 107 (100) | 42 (100) |
Values are expressed as number of patients (%); 25(OH)D: 25 hydroxyvitamin D; BMI: body mass index; KT: kidney transplant; CNI: calcineurin inhibitor.
*
Chi-square test: p=0.055.